Twist Bioscience Corp — Director's Dealing 2020

Feb 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Twist Bioscience Corp (TWST)
CIK: 0001581280
Period of Report: 2020-02-06

Reporting Person: Weiss Patrick (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-06	Common Stock	M	6081	$26.66	Acquired	85950	Direct
2020-02-06	Common Stock	S	6081	$28.158	Disposed	79869	Direct
2020-02-06	Common Stock	M	1599	$26.66	Acquired	81468	Direct
2020-02-06	Common Stock	S	1599	$28.158	Disposed	79869	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-06	Stock Option (right to buy)	$26.66	M	6081	Acquired	2028-11-18	Common Stock (6081)	Direct
2020-02-06	Stock Option (right to buy)	$26.66	M	1599	Acquired	2028-11-18	Common Stock (1599)	Direct

Footnotes

F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.

F2: Represents the aggregate of sales effected on the same day at different prices.

F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $28.00 to $28.29 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

F4: The option is immediately exercisable. 20% of the shares subject to the option vested on October 31, 2019, and 1/60th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.